WebApr 21, 2024 · Cash position as of March 31, 2024. GenSight Biologics’ cash and cash equivalents totaled €36.0 million as of March 31, 2024, compared to €44.3 million as of December 31, 2024. The operating ... WebJul 28, 2024 · The financial income in the first half of 2024 amounted to €1.3 million compared to € (1.6) million over the same period in 2024. The variation is primarily driven by a non-cash calculated income related to the bond financing with Kreos, impacted by the share price decrease over the period. The Company’s net loss for the first half of ...
SIGHT - Gensight Biologics SA Stock Price Quote - XPAR
WebStock analysis for GenSight Biologics SA (SIGHT:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Web102 rows · Discover historical prices for SIGHT.PA stock on Yahoo Finance. View daily, weekly or monthly format back to when GenSight Biologics S.A. stock was issued. somersworth nh town clerk
GenSight Biologics Announces the Partial Conversion of …
WebFeb 5, 2024 · Summary of all time highs, changes and price drops for GenSight Biologics; Historical stock prices; Current Share Price: €2.30: 52 Week High: €4.59 WebGenSight Biologics S.A. (SIGHT) EUR0.025 Sell: €2.34 Buy: €2.40 €0.19 (8.92%) Market closed Prices as at close on 31 March 2024 Turn on streaming prices Add to watchlist This stock can be... WebApr 8, 2024 · The Company’s net loss in 2024 amounted to €28.6 million compared to €34.0 million in 2024. The average weighted number of shares increased to 45.2 million in 2024 from 35.1 million in 2024 leading... somersworth nh tax map